Excited to share our work in the Gibson lab at @Stanford published in @NeuroCellPress! We show that the circadian factor BMAL1 regulates oligodendroglia and myelination, contributing to sleep regulation.
https://t.co/6clXNvvLyV
1/13
How is the Biden-Harris Admin working to ensure taxpayer-funded research data & publications advance innovation for ALL Americans?
Today, @WHOSTP is releasing new guidance to make this research immediately available to the public at no cost. Learn more⤵️ https://t.co/71Sqs0Jeou
$GRPH Update: The first patient has been dosed in our Phase 1/2 trial evaluating our investigational next-generation #GeneEditing therapy for #SickleCellDisease. Read more: https://t.co/1g8zGunVnY
Honored to be featured in @GraphiteBio's core value about exploration and curiosity. These characteristics are central to my role as a scientist, and I’m proud to work at a company that is committed to discovering and developing the next scientific breakthroughs for patients.
Our #CoreValue #3: "We explore with purpose." We are committed to being curious. We ask big questions and are open to unexpected answers. We consider 'yes' before 'no,' and believe discovering the unknown today will change the world tomorrow.
our pandemic baby is out for the world to read! lot's of socially distanced isolation in the microscope room to help make this possible! congrats team!
Well it’s finally here…our lab’s first preprint/paper 🍾😊 📝
I first started thinking about the intersection of circadian and myelin biology over a decade ago. This work was the foundation of my research statements for faculty job applications and 1/2
#AACRFellows John E. Dick, PhD, receives the Inaugural AACR Award for Outstanding Achievement in Blood Cancer Research at the #AACR22 Opening Ceremony. This new award recognizes meritorious achievements in basic, translational, or clinical research related to blood cancer.